Startup profile · funding coverage
WHOOP funding, valuation and investors
Subscription wearable tracking recovery, strain, and sleep for athletes and wellness users.
Keep track of WHOOP
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series G
$575M · March 2026
Latest known valuation
$10.1B
Series G · March 2026
Total disclosed equity funding
$575M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Boston, MA
Investors in latest funding
Other: Collaborative Fund
Overview
WHOOP sells a screenless wrist wearable focused on recovery, strain, and sleep coaching via continuous HRV and biometric monitoring. Founded in Boston, the company built a premium subscription model without a screen, expanding into corporate wellness and clinical partnerships. In March 2026 WHOOP announced $575M Series G at a $10.1B valuation per TechCrunch, with Collaborative Fund among directory investors.
Why WHOOP is interesting
WHOOP proved a screenless, subscription-only wearable can reach decacorn valuation when the metric is recovery—not steps—and employers/payers care about outcomes.
Product & use cases
Hardware sensor plus membership app delivering recovery scores, strain targets, sleep coaching, and longitudinal health trends.
- Athlete training load management
- Sleep and recovery optimization for executives
- Corporate wellness and team sports programs
Key facts
- Series G (Mar 2026): $575M at $10.1B valuation
- Screenless recovery wearable + subscription
- TechCrunch Mar 2026 coverage
- Collaborative Fund on cap table
Funding history (newest first)
Series G
2026-03 $575M Valuation: $10.1BSource: https://techcrunch.com/2026/03/31/whoop-valuation-10b-series-g-fundraise/
Investors in our directory
Funds linked from WHOOP's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Brand in performance recovery niche; subscription ARPU and community versus commodity fitness trackers.
Premium wearables face Apple bundle pressure; WHOOP defends with coaching UX and sports partnerships. Series G tests whether clinical/employer channels extend TAM beyond prosumer athletes.
-
Oura Ring direct
Recovery-focused wearable competitor.
-
Apple Watch incumbent
General health with broader features and screen.
-
Garmin adjacent
Endurance sports devices with training metrics.
Notable stories
- VCT noted CDC sleep data as macro context — roughly 1 in 3 U.S. adults insufficient sleep — underpinning recovery product demand.
Industries
Related funding articles
Venture Capital Tracker pieces that cover WHOOP's financing or category context.
FAQs about WHOOP
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.